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Prognostic factor and optimum surgical treatment
for the ampullary adenocarcinoma
Toshihiro Watanabe, Yuya Ashitomi, Ichiro Hirai, Wataru Kimura
Backgrounds: This study aims to identify a clinicopathological prognostic factor for the ampullary 
adenocarcinoma and optimum surgical treatment.
Methods: The study subjects were 32 patients diagnosed with ampullary adenocarcinoma 
who underwent resection between 1999 to 2016. Retrospectively, the correlation between the 
clinicopathological factor and prognosis was analyzed by Kaplan-Meier method.
Results: The mean age of the 32 subjects was 63.2 year, and they comprised 20 men and 12 
women. Pancreaticoduodenectomy was performed in 28 patients and trans-duodenal ampullary 
resection was performed in 4 patients. Duodenal invasion, pancreas invasion, lymph node metastases, 
perineural invasion and evidence of residual tumor were statistically significant prognostic factors 
by the univariate analysis. Lymph node metastases was only independent prognostic factor by the 
multivariate analysis. the 5-years survival rate was significantly lower（28.6%）for patients in whom 
present regional lymph node metastases compared with those in absent（91.7%）, but significantly 
higher compared with in whom present para-aortic lymph node metastases. We had an experience 
with recurrence of lymph nodes metastases in the early cancer not invade sphincter of Oddi at 3 
years after surgery.
Conclusion: The standard curative operation for the ampullary adenocarcinoma is pancreaticoduode-
nectomy. In addition, ampullary resection is considered as one option for patients with carcinoma in 
situ and elderly patients who tolerate surgery poorly.
Key words: ampullary adenocarcinoma, pancreaticoduodenectomy, trans-duodenal ampullary 
resection, lymph node metastases
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